Details for: JAMP DUTASTERIDE
Company: JAMP PHARMA CORPORATION
| DIN | DIN name | Active Ingredient(s) | Strength | Dosage Form | Route of Administration |
|---|---|---|---|---|---|
| 02484870 | JAMP DUTASTERIDE | DUTASTERIDE | 0.5 MG | CAPSULE | ORAL |
Consumer Information
This information was provided by the drug’s manufacturer when this drug product was approved for sale in Canada. It is designed for consumers and care givers. It is a summary of information about the drug and will not tell you everything about the drug. Contact your doctor or pharmacist if you have any questions about the drug.
What the medication is used for
What the medication is used for:
JAMP DUTASTERIDE is used alone (monotherapy) in the treatment of symptomatic benign prostatic hyperplasia (BPH) in men with enlarged prostates
JAMP DUTASTERIDE is also used in combination with the alpha blocker, tamsulosin, in the treatment of moderate to severe symptomatic BPH in men with enlarged prostates. Combination therapy was also shown to be better than tamsulosin, but not dutasteride at reducing the risk of acute urinary retention (or where patient suddenly cannot urinate at all) and/or the need for BPH related surgery.
JAMP DUTASTERIDE is not approved for use in the prevention of prostate cancer.
What it does
Prostate growth is caused by a hormone in the blood called dihydrotestosterone (DHT). JAMP DUTASTERIDE belongs to a group of medicines called 5 alpha-reductase enzyme inhibitors. JAMP DUTASTERIDE lowers DHT production in the body, leading to a shrinkage of the enlarged prostate in most men, which leads to improvements in BPH symptoms and improved urinary flow, reduced risk of acute urinary retention (or where patient suddenly cannot urinate at all), and reduced risk of the need for BPH related surgery.
JAMP DUTASTERIDE is also used with another medicine called tamsulosin, an alpha blocker, which acts by relaxing smooth muscle in the prostate and bladder neck at the site of obstruction, resulting in improvements in BPH symptoms and improved urinary flow.
Symptoms of BPH may be seen to improve after 3 months of treatment with JAMP DUTASTERIDE, however, it may take up to 6 months to know if treatment with JAMP DUTASTERIDE will be beneficial.
When it should not be used
- Women and children should never take JAMP DUTASTERIDE.
- Do not take JAMP DUTASTERIDE if you are allergic to dutasteride or other alpha-reductase inhibitors or any of the other ingredients of JAMP DUTASTERIDE.
What the medicinal ingredient is
dutasteride
What the non-medicinal ingredients are
Nonmedicinal ingredients in your medicine include gelatin (from certified, BSE-free, non-porcine sources), glycerin, iron oxide yellow, lecithin, medium chain triglycerides, purified water, titanium dioxide. The capsules are printed with edible black ink containing iron oxide black as the colourant, isopropyl alcohol, N-butyl alcohol, propylene glycol, shellac.
Each capsule for oral administration contains 0.5 mg of dutasteride dissolved in a mixture of butylated hydroxytoluene and mono-and di-glycerides of caprilic/capric acids.
What dosage form it comes in
Soft gelatin capsules. Each capsule contains 0.5 mg of dutasteride.
Warnings and precautions
Serious Warnings and Precaution
- JAMP DUTASTERIDE is for use by men only
- Women who are pregnant, or who may become pregnant. Should not handle JAMP DUTASTERIDE as it may pass through the skin. JAMP DUTASTERIDE may affect the normal development of the external genital organs in a male baby.
Heart failure (the heart does not pump blood as well as it should) was reported more often in patients taking JAMP DUTASTERIDE and an alpha-blocker, tamsulosin, in clinical studies than in patients taking JAMP DUTASTERIDE . It is not known if taking JAMP DUTASTERIDE and an alpha-blocker caused heart failure.
BEFORE you use JAMP DUTASTERIDE, talk to your doctor or pharmacist if:
- You have or have had liver problems
- You have or have had prostate cancer or urinary tract disease.
What are the special precautions about MEDDUTASTERIDE?
- Do not donate blood while taking MED DUTASTERIDE and for at least 6 months after you have stopped taking JAMP DUTASTERIDEin order to prevent giving JAMP DUTASTERIDE to a pregnant woman through blood transfusion.
- In a clinical study of men aged 50 to 75 years with a recent negative biopsy for prostate cancer and an increased prostate specific antigen (PSA) blood test, men taking dutasteride had a serious form of prostate cancer more often than men who did not take dutasteride.
You must see your doctor regularly. While taking JAMP DUTASTERIDE, you must have regular checkups, including digital rectal examination and PSA examination. Follow your doctor’s advice about when to have these checkups.
Checking for prostate cancer A man can have BPH and prostate cancer at the same time. Prior to treatment with JAMP DUTASTERIDE, you should have a thorough urological evaluation to determine the severity of your condition, and to rule out the need for immediate surgery or the possibility of prostate cancer.
About Prostate Specific Antigen (PSA)If a doctor asks you to have a Prostate Specific Antigen (PSA) test which is used for screening prostate cancer, you should tell your doctor that you are taking JAMP DUTASTERIDE. JAMP DUTASTERIDE can lower the PSA test result. A low PSA level may give you a false sense of security about your risk for prostate cancer. Your doctor is aware of this effect and can still use PSA to see if you might have prostate cancer. Increases in your PSA levels while on treatment with JAMP DUTASTERIDE (even if the PSA levels are in the normal range) should be evaluated by your doctor.
Interactions with this medication
Interactions with other medicinesSome medicines can react with JAMP DUTASTERIDE and may make it more likely that you will have side effects. Some of these medicines may include:
- Verapamil or diltiazem (for high blood pressure).
- Ritonavir (for HIV).
- Ketaconazole (for fungal infections).
- Ciprofloxacin or troleandomycin (for bacterial infections).
- Cimetidine (for heart burn).
- Certain herbal medicines such as St. John’s Wort or Milk Thistle.
Make sure your doctor knows if you are taking any of these, or other medicines. Your dose of JAMP DUTASTERIDE may need to be reduced. Remember to include all medicines, herbal remedies or dietary supplements, such as vitamins, iron or calcium, which you have bought yourself without a prescription.
Do not eat grapefruit or drink grapefruit juice while taking JAMP DUTASTERIDE. This drink is known to increase the blood levels of some drugs in the body.
Proper use of this medication
Always take JAMP DUTASTERIDE exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure.
Usual dose:
Monotherapy:One JAMP DUTASTERIDE 0.5 mg capsule once a day
Combination therapy: One JAMP DUTASTERIDE 0.5 mg capsule once a day with one tamsulosin 0.4 mg once a day.
- Swallow the capsule whole. DO NOT chew or open the capsules. Contact with the contents of the capsules may make your mouth or throat sore.
- The capsules can be taken with or without food.
Do not share your medication with others.
Overdose:
Missed Dose:
If you miss a dose, you can just take the next scheduled dose. Don’t take any extra capsules to make up for doses you forgot to take.
Side effects and what to do about them
The most common side effects of dutasteride , taken alone or in combination with tamsulosin, are not being able to achieve or maintain an erection* (impotence), decrease in libido* (decreased desire to have sex or a reduced sex drive), changes or problems with ejaculations* (including a decrease in amount of semen released during sex) and breast swelling or tenderness
If breasts swelling or tenderness becomes troublesome, or if you notice breast lumps or nipple discharge, you should talk to your doctor about these changes. Additionally, some people may experience dizziness when taking JAMP DUTASTERIDE with tamsulosin.
Rare side effects (may affect up to 1 in 1,000 people) of hair loss (usually from the body) or abnormal hair growth have been reported.
Very rare side effects (1 in 10,000 people) of allergic reactions and depressed mood and pain and swelling in the testicles have been reported.
Breast cancer has been reported in patients taking dutasteride however, the relationship between long-term use of dutasteride and breast cancer is not known.
*In a small number of people some of these events may continue after you stop taking dutasteride.| Symptom / effect | Talk with your doctor or pharmacist Only if severe | Talk with your doctor or pharmacist In all cases | Stop taking drug and call your doctor or pharmacist |
|---|---|---|---|
| Very Rare | |||
| Sudden wheeziness or chest tightness | ✔ | ||
| Swelling of eyelids, face or lips | ✔ | ||
| Lumpy skin rash or “hives” anywhere on the body | ✔ | ||
If you notice these side effects and any other side effects not mentioned in this leaflet, tell your doctor or pharmacist.
This is not a complete list of side effects. For any unexpected effects while taking JAMP DUTASTERIDE, contact your doctor or pharmacist.How to store
- Store JAMP DUTASTERIDE capsules between 15°C and 30°C.
- Keep out of the reach and sight of children.
- Return any cracked or leaking capsules to your pharmacist for replacement.
- Return any unused capsules to a pharmacist.
Reporting side effects
You can report any suspected side effects associated with the use of health products to Health Canada by:
- Visiting the Web page on Adverse Reaction Reporting (https://www.canada.ca/en/healthcanada/services/drugs-health-products/medeffectcanada/adverse-reaction-reporting.html) for information on how to report online, by mail or by fax; or
- Calling toll-free at 1-866-234-2345.
NOTE: Contact your health professional if you need information about how to manage your side effects. The Canada Vigilance Program does not provide medical advice.
More information
This document plus the full product monograph, prepared for health professionals can be found at:
JAMP Pharma Corporation
1310 rue Nobel
Boucherville, Québec
J4B 5H3
JAMP Pharma Corporation at:
1-866-399-9091
This leaflet was prepared by JAMP Pharma Corporation Date of Revision: January 22, 2019.